Get Your Personalized Supplement StackSupplement Stack Quiz

Polypodium Vulgare Root Powder

Also known as: Polypodium vulgare L., Common polypody, Polypody fern, Polypodium vulgare

Overview

Polypodium vulgare root powder is derived from the rhizome of the Polypodium vulgare fern, a plant with a history of use in traditional medicine systems like Unani and European herbal medicine. It has been used for various ailments, including respiratory, hepatic, and neurological conditions. The root contains bioactive compounds such as triterpenoids, polyphenols, and osladin, which are believed to contribute to its pharmacological effects. While research on Polypodium vulgare is moderately mature, with some pharmacodynamic studies and preclinical evidence, there is a lack of high-quality clinical trials and systematic reviews specifically on the root powder form. It is available primarily as a root powder or extract and is sourced from the rhizomes of the fern. Further research is needed to fully understand its potential benefits and risks in humans.

Benefits

Polypodium vulgare root extract has demonstrated several potential benefits in preclinical studies. It exhibits CNS depressant activity, shown by decreased spontaneous motor activity and potentiation of hypnotic effects in animal models, suggesting potential calming effects. It also shows anticonvulsant properties against induced seizures in rats, likely due to CNS depression. The rhizome extract has antibacterial effects against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria, attributed to secondary metabolites like triterpenoids and polyphenols. Experimental studies in animals indicate muscle-relaxing properties, potentially beneficial for conditions involving smooth muscle spasms. Historically, it has been used for jaundice, dropsy, scurvy, spleen disorders, epilepsy, and rheumatoid conditions, though clinical evidence for these indications is lacking or preliminary. Clinical significance in humans remains unclear due to the paucity of rigorous randomized controlled trials (RCTs) meeting high methodological standards.

How it works

Polypodium vulgare's mechanism of action involves several pathways. Its CNS depressant effects appear to act on subcortical centers in the brain, reducing motor activity and enhancing sedative effects, possibly by modulating neurotransmitter systems involved in CNS excitability. The antimicrobial action is attributed to secondary metabolites such as triterpenoids and polyphenols, which disrupt bacterial growth and viability, with osladin identified as a key antimicrobial compound in the rhizome. The extract reverses contractions induced by high potassium and carbachol in isolated smooth muscle preparations, suggesting calcium channel blockade or muscarinic receptor antagonism as potential pathways. Absorption and bioavailability data are limited, with most studies focusing on aqueous or methanolic extracts in animal models.

Side effects

Animal studies indicate that high doses of Polypodium vulgare (1000 mg/kg) may impair motor coordination temporarily; however, lower doses show minimal adverse effects. Due to limited clinical data, there are no well-documented side effects in humans. However, CNS depression-related effects such as sedation may occur at higher doses. There is a potential for additive CNS depressant effects if combined with other sedatives; however, no specific interaction studies are available. Due to lack of research, contraindications are not well-defined; caution is advised in patients with CNS depression or on CNS-active medications. There is no data on use in pregnancy, lactation, children, or elderly. More research is needed to fully understand the safety profile of Polypodium vulgare.

Dosage

The minimum effective dose of Polypodium vulgare has not been established in humans; animal studies used doses ranging from 100 to 1000 mg/kg. The optimal dosage is also unknown; traditional use and preclinical studies suggest doses around 300 mg/kg in animals for CNS effects. The maximum safe dose is not clearly defined; high doses in animals caused motor impairment. There is no clinical data on timing or duration. Aqueous extracts are commonly studied; root powder dosing in humans is not standardized. Absorption factors are unknown but likely influenced by extract preparation. No required cofactors have been identified. Due to limited human data, it is crucial to consult with a healthcare professional before using Polypodium vulgare.

FAQs

Is Polypodium vulgare root powder safe?

Animal data suggest safety at moderate doses, but human safety data are insufficient. Consult with a healthcare professional before use.

What conditions can it treat?

Traditionally used for CNS disorders, infections, and inflammatory conditions, but robust clinical evidence is lacking. More research is needed.

How quickly does it work?

Animal studies show CNS effects within hours; human onset is unknown. Effects may vary depending on the individual and the condition being treated.

Can it be combined with other supplements?

Caution is advised with CNS depressants; no formal interaction studies are available. Consult with a healthcare provider before combining.

Research Sources

https://onlinelibrary.wiley.com/doi/pdf/10.1155/2022/3599246 – This systematic review examined the use of herbal medicines for Premenstrual Syndrome (PMS). While Polypodium vulgare was not specifically highlighted, the review suggests that herbal medicines, in general, may reduce PMS symptoms. However, this source provides no direct evidence for the efficacy of Polypodium vulgare itself.
https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-polypodium-vulgare-l-rhizoma_en.pdf – This EMA assessment report details a preclinical animal study where Polypodium vulgare root aqueous extract reduced spontaneous motor activity, potentiated pentobarbitone-induced sleep, and showed anticonvulsant activity at doses of 100-300 mg/kg in rats and mice. High doses (1000 mg/kg) impaired motor coordination in 33% of animals, suggesting CNS depression likely mediated these effects. The study is limited by its small sample size and animal model.
https://pubmed.ncbi.nlm.nih.gov/2583745/ – This animal pharmacodynamic study confirmed the CNS depressant effects of Polypodium vulgare, including decreased motor activity and prolonged pentobarbitone sleep time in rats. The study is limited by being conducted on an animal model and lacking clinical trials. The findings suggest potential sedative properties but require further investigation in humans.
https://ijpsr.com/bft-article/polypodium-vulgare-linn-a-versatile-herbal-medicine-a-review/ – This review article discusses Polypodium vulgare as a versatile herbal medicine. It highlights its traditional uses and potential therapeutic properties, including its antimicrobial and anti-inflammatory effects. The review emphasizes the need for further research to validate these claims and determine its safety and efficacy in humans.
https://www.unanijournal.com/articles/243/7-2-11-798.pdf – This article explores the traditional uses of Polypodium vulgare in Unani medicine. It describes its applications for various ailments, including liver disorders, respiratory issues, and neurological conditions. The article underscores the importance of further scientific investigation to confirm these traditional uses and understand the underlying mechanisms of action.